Second Sight Medical (EYES) Tops Q1 EPS by 3c

Second Sight Medical (NASDAQ: EYES) reported Q1 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
• Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
• Aeroflex Holdings (ARX) Tops Q2 EPS by 15c